Tumor initiation and routine maintenance are largely dependent on a little portion of cancer cells, named tumor-initiating cells or cancer stem cells. Those kinds of cells show indefinite self-renewal capacity, prospective to induce tumorigenesis, and resistance to chemotherapeutic agents 5, 6. Traditional anti-cancer medicines focus on promptly multiplying tumor cells; https://fernandowcglp.blog4youth.com/30277306/helping-the-others-realize-the-advantages-of-dasatinib